血液透析患者对新冠病毒奥密克戎BA.5和XBB.1.5的中和反应。 - Suppr

Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients.

作者信息

Affeldt Patrick, Brensing Karl August, Heger Eva, Wirtz Maike, Steger Gertrud, Koehler Felix Carlo, Benzing Thomas, Stippel Dirk, Klein Florian, Kurschat Christine, Müller Roman-Ulrich, Di Cristanziano Veronica

机构信息

Department II of Internal Medicine and Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

出版信息

Clin Kidney J. 2023 Sep 12;16(12):2757-2759. doi: 10.1093/ckj/sfad230. eCollection 2023 Dec.

DOI:10.1093/ckj/sfad230

PMID:38046037

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10690076/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b3b/10690076/8476ef3526c4/sfad230fig1.jpg

相似文献

Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients.血液透析患者对新冠病毒奥密克戎BA.5和XBB.1.5的中和反应。

Clin Kidney J. 2023 Sep 12;16(12):2757-2759. doi: 10.1093/ckj/sfad230. eCollection 2023 Dec.

Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.奥密克戎亚谱系中保守的刺突蛋白中和抗体位点逐渐丧失，但 T 细胞免疫得以保留。

Cell Rep. 2023 Aug 29;42(8):112888. doi: 10.1016/j.celrep.2023.112888. Epub 2023 Jul 31.

SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.严重急性呼吸综合征冠状病毒2型奥密克戎XBB亚变体在老年人群中表现出增强的融合性和显著的免疫逃逸能力，但对泛冠状病毒融合抑制剂高度敏感。

J Med Virol. 2023 Mar;95(3):e28641. doi: 10.1002/jmv.28641.

Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.在接受 Evusheld 治疗的个体中，对 SARS-CoV-2 奥密克戎 BA.2、BA.2.75、BA.2.76、BA.5、BF.7、BQ.1.1 和 XBB.1.5 的血清中和作用。

J Med Virol. 2023 Jul;95(7):e28932. doi: 10.1002/jmv.28932.

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations.二价新冠疫苗接种者对BQ.1.1、BN.1和XBB.1的中和活性：按既往感染类型和疫苗配方进行比较

Vaccines (Basel). 2023 Aug 4;11(8):1320. doi: 10.3390/vaccines11081320.

Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy.意大利不同疫苗接种方案接种 6 个月后对 SARS-CoV-2 奥密克戎亚系的免疫反应评估。

Acta Trop. 2023 Dec;248:107042. doi: 10.1016/j.actatropica.2023.107042. Epub 2023 Oct 18.

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2.一种重组蛋白XBB.1.5 RBD/明矾/磷酸胞苷疫苗可引发针对新冠病毒奥密克戎亚变体的高中和抗体滴度。

Vaccines (Basel). 2023 Oct 1;11(10):1557. doi: 10.3390/vaccines11101557.

A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB.一种新冠DNA候选疫苗可诱导产生针对多种新冠病毒变种的广泛中和抗体，包括目前正在传播的奥密克戎BA.5、BF.7、BQ.1和XBB变种。

Vaccines (Basel). 2023 Mar 31;11(4):778. doi: 10.3390/vaccines11040778.

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron.二价 BNT162b2 疫苗接种的医护人员（有或无风险因素）或感染奥密克戎后，对奥密克戎亚谱系（BA.2/BA.5/BQ.1.1/XBB/XBB.1.5）的中和作用。

Sci Rep. 2023 Oct 13;13(1):17404. doi: 10.1038/s41598-023-44484-x.

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children.儿童感染 SARS-CoV-2 或接种疫苗后对奥密克戎 BQ.1、BQ.1.1 和 XBB.1 变异株的中和作用。

Nat Commun. 2023 Dec 1;14(1):7952. doi: 10.1038/s41467-023-43152-y.

引用本文的文献

SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine.接受和未接受第五剂更新后的科兴原始/奥密克戎BA.4-5疫苗接种的血液透析患者的SARS-CoV-2中和能力

Vaccines (Basel). 2024 Mar 15;12(3):308. doi: 10.3390/vaccines12030308.

本文引用的文献

Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of breakthrough infections in haemodialysis patients.四次接种疫苗后对奥密克戎BA.1、BA.5和BQ.1.1的SARS-CoV-2纵向中和作用以及血液透析患者突破性感染的影响。

Clin Kidney J. 2023 Jun 24;16(12):2447-2460. doi: 10.1093/ckj/sfad147. eCollection 2023 Dec.

Serum Neutralization of Omicron XBB.1.5 in Kidney Transplant Recipients After Bivalent mRNA Booster Vaccination.二价mRNA加强疫苗接种后肾移植受者血清对奥密克戎XBB.1.5的中和作用

Kidney Int Rep. 2023 May 26;8(8):1665-8. doi: 10.1016/j.ekir.2023.05.020.

A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2.一种重组刺突-XBB.1.5蛋白疫苗可诱导针对包括XBB.1.5在内的SARS-CoV-2奥密克戎变体的广谱免疫反应。

MedComm (2020). 2023 Apr 26;4(3):e263. doi: 10.1002/mco2.263. eCollection 2023 Jun.

Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5.深度中和逃逸和增强的宿主细胞进入是快速传播的新冠病毒谱系XBB.1.5的特征。

Cell Mol Immunol. 2023 Apr;20(4):419-422. doi: 10.1038/s41423-023-00988-0. Epub 2023 Mar 3.

BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer.BQ.1.1、XBB.1 和 XBB.1.5 对癌症患者二价 mRNA COVID-19 加强针的中和作用。

Cancer Cell. 2023 Apr 10;41(4):649-650. doi: 10.1016/j.ccell.2023.02.003. Epub 2023 Feb 9.

Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.对奥密克戎BA.4-BA.5二价加强针的抗体反应

N Engl J Med. 2023 Feb 9;388(6):567-569. doi: 10.1056/NEJMc2213907. Epub 2023 Jan 11.

Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.血液透析患者和肾移植受者对第三和第四剂 COVID-19 疫苗的免疫反应。

Viruses. 2022 Nov 26;14(12):2646. doi: 10.3390/v14122646.

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.来自mRNA二价加强针的针对BA.2.75.2、BQ.1.1和XBB的中和作用。

N Engl J Med. 2023 Jan 12;388(2):183-185. doi: 10.1056/NEJMc2214293. Epub 2022 Dec 21.

Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster.原始mRNA疫苗或BA.5二价加强针对SARS-CoV-2奥密克戎BA.2.75.2、BQ.1.1和XBB.1的中和作用较低。

Nat Med. 2023 Feb;29(2):344-347. doi: 10.1038/s41591-022-02162-x. Epub 2022 Dec 6.

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.BNT162b2疫苗在南非针对奥密克戎亚谱系的有效性和持久性

N Engl J Med. 2022 Oct 6;387(14):1332-1333. doi: 10.1056/NEJMc2210093. Epub 2022 Sep 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献